ReviewMovement disorders : official journal of the Movement Disorder Society2014
Psychiatric issues in cognitive impairment.
Review in Movement disorders : official journal of the Movement Disorder Society, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Associations of Apathy and Depressive Symptoms With Frailty Domains in Individuals Aged 75 Years Old: A Cross-Sectional Study.Geriatrics & gerontology international · 2026Article
- Non-Motor Fluctuations in Parkinson's Disease: Underdiagnosed Yet Important.Journal of movement disorders · 2025Article
- Validation of the Portuguese MDS-UPDRS: Challenges to Obtain a Scale Applicable to Different Linguistic Cultures.Movement disorders clinical practice · 2025Article
- Specific neuropsychiatric symptoms are associated with functional decline trajectories in Alzheimer's disease and Lewy body dementia: a five-year follow-up study.Frontiers in medicine · 2023Article
- Challenges and Considerations in Treating Negative and Cognitive Symptoms of Schizophrenia Spectrum Disorders.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2022Article
- Gene Panel Sequencing Identifies Novel Pathogenic Mutations in Moroccan Patients with Familial Parkinson Disease.Journal of molecular neuroscience : MN · 2021Article
- Common and unique connectivity at the interface of motor, neuropsychiatric, and cognitive symptoms in Parkinson's disease: A commonality analysis.Human brain mapping · 2020Article
- Mild behavioral impairment in Parkinson's disease is associated with altered corticostriatal connectivity.NeuroImage. Clinical · 2020Article
- Conditional deletion of Ndufs4 in dopaminergic neurons promotes Parkinson's disease-like non-motor symptoms without loss of dopamine neurons.Scientific reports · 2017Article
- Cognitive phenotypes in parkinson's disease differ in terms of brain-network organization and connectivity.Human brain mapping · 2017Article
- Succinobucol, a Non-Statin Hypocholesterolemic Drug, Prevents Premotor Symptoms and Nigrostriatal Neurodegeneration in an Experimental Model of Parkinson's Disease.Molecular neurobiology · 2017Article
- Neuropsychiatric symptoms in untreated Parkinson's disease.Neuropsychiatric disease and treatment · 2017Review
- A novel de novo mutation in ATP1A3 and childhood-onset schizophrenia.Cold Spring Harbor molecular case studies · 2016Article
- Review
- The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2016Review
- Laboratory assessments in the course of Parkinson's disease: a clinician's perspective.Journal of neural transmission (Vienna, Austria : 1996) · 2016Review
- Chronic deep brain stimulation of the medial forebrain bundle reverses depressive-like behavior in a hemiparkinsonian rodent model.Experimental brain research · 2015Article
- Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo.Neurobiology of aging · 2015Article
- Neuropsychiatric Symptoms and Functional Connectivity in Mild Cognitive Impairment.Journal of Alzheimer's disease : JAD · 2015Article
- Introduction: the importance of cognition in movement disorders.Movement disorders : official journal of the Movement Disorder Society · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Neuropsychiatric symptoms (NPS) such as depression, hallucinations and apathy commonly occur in Parkinson's disease (PD) and have major clinical consequences including a negative impact on quality of life. This review discusses the epidemiology, clinical features, diagnostic procedures and treatment issues of NPS in PD and related disorders in the perspective of cognitive impairment, focusing on depression, anxiety, visual hallucinations, apathy, sleep disturbances, impulse control disorder and non-motor fluctuations. The majority of NPS are more common in PD patients with dementia, possibly related to shared underlying pathologies. Recent studies also suggest that NPS are associated with mild cognitive impairment in PD, in particular with the amnestic type. Accurate diagnosis of NPS is important but can be difficult, due to overlapping symptoms and similar appearance of symptoms of motor symptoms of parkinsonism, cognitive impairment, mood disorders and apathy. There are few systematic studies focusing on the management of NPS in PD with cognitive impairment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.